CMS Overpaid $4.6M For Drugs Last Quarter, Report Says

Law360, New York (August 14, 2012, 1:27 PM EDT) -- The U.S. Centers for Medicare and Medicaid Services overpaid for prescription drugs by $4.6 million in the second quarter of 2012, while a soon-to-be-implemented CMS price-adjustment program could have saved the agency $4.2 million during that time, a report said Monday.

A quarterly analysis issued by the U.S. Department of Health and Human Services inspector general found that CMS paid reimbursements for drugs covered by Medicare's outpatient benefit — known as Medicare Part B — based on the drugs' average sales prices, even though they exceeded...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.